Clinical trial Recruiting at 1 site Observational Ages 18 and up

Pregnancy and postpartum breastfeeding support for people with gestational diabetes

Official title: Preventing Type 2 Diabetes Following Gestational Diabetes: Implementation Mapping for a Multilevel Breastfeeding Support Strategy

Run by University of California, Davis · NCT07176793 · Data updated 2026-11-12

This project will try a co-designed breastfeeding support program for pregnant and postpartum people with gestational diabetes to help lower their future risk of type 2 diabetes.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment10 (estimated)
SponsorUniversity of California, Davis
Academic / other
Locations1 site (Sacramento, California)
StatusRecruiting
StartedMarch 23, 2026
Main results expectedDecember 30, 2026
Study endsDecember 30, 2026
Registry record updatedSeptember 14, 2026
Trial IDNCT07176793 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal participants are English-speaking adults (age 18 or older) who are pregnant or recently postpartum with a diagnosis of gestational diabetes, as well as clinicians and health system leaders involved in perinatal care.

Probably not a fit

People under 18, non-English speakers, those without a history of gestational diabetes, or those unable to travel to UC Davis are unlikely to benefit from participating.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers at UC Davis will use implementation mapping and the Consolidated Framework for Implementation Research (CFIR) to co-design a multilevel breastfeeding support strategy with patients, clinicians, and health system leaders. The work will include focus groups and stakeholder interviews to identify barriers and solutions and will map implementation strategies tailored to the local health system. The goal is to create practical workflows and supports (for example, lactation consultation access and postdischarge follow-up) that can be adopted at UC Davis Health. The project is observational and will take place over about one year at UC Davis Medical Center in Sacramento, California.

Why it matters

Potential benefit: If successful, the program could increase breastfeeding duration among people with gestational diabetes and reduce their long-term risk of developing type 2 diabetes.

How similar studies have gone: Breastfeeding and lactation-support programs have been shown to improve breastfeeding rates and reduce maternal diabetes risk, but using implementation mapping specifically to design GDM-focused breastfeeding strategies is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* ≥18 years old and able to communicate in English
* Fits into one of the following:

  1. patients with GDM who are recently pregnant and/or postpartum;
  2. health care providers (nurses, physicians, lactation consultants, etc.) who would implement the strategy
  3. executive leadership

Exclusion Criteria:

* Subjects not meeting the inclusion criteria will be considered ineligible for participation

Where it's running

  • UC Davis Medical Center
    Sacramento, California, United States
    Recruiting

Study contacts

  • Principal investigator: Adrienne Hoyt-Austin, DO, MAS, IBCLC — UC Davis Health
  • Study coordinator: Adrienne Hoyt-Austin, DO, MAS, IBCLC
  • Email: aehoyt@health.ucdavis.edu
  • Phone: 916-734-4580

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.